Zhi-Feng Pang
Zhi-Feng Pang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Guang-Ming Zhang
Department of Infectious Disease Prevention and Control, Jinhua Center for Disease Control and Prevention, China
2 shared publications Zhen Ye
Department of Infectious Disease Prevention and Control, Yiwu Center for Disease Control and Prevention
2 shared publications- Guangming Zhang
Jinhua Center for Disease Control and Prevention, Jinhua, P. R. China
1 shared publication Guo-Yong Jiang
Department of Infectious Disease Prevention and Control, Lanxi Center for Disease Control and Prevention
1 shared publicationJuan-Juan He
Jinhua Municipal People’s Hospital
1 shared publicationKaizhi Bai
Infectious Disease Control Section, Jinhua Center for Disease Control and Prevention, Jinhua, Zhejiang, China
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1835645
Economic burden of Mycoplasma pneumoniae infection in Jinhua City, China: a multicenter cross-sectional study
Background: Mycoplasma pneumoniae (MP) infection is a major cause of respiratory tract infections, particularly among children. However, quantitative evidence regarding its economic burden in China remains limited. Methods: A multicenter cross-sectional study was performed in Jinhua, China. Between October 2024 and March 2025, patients with laboratory-confirmed MP infection were enrolled using a multistage stratified random sampling approach. Data regarding direct, indirect, and intangible costs were collected via structured questionnaires and hospital information systems. Univariate analyses and generalized linear models (GLM) with a gamma distribution and log link function were employed to explore factors associated with the economic burden of MP infection. Results: A total of 582 patients were included, comprising 372 outpatients and 210 inpatients. The mean total cost per inpatient (¥6,289.21) was 7.69 times higher than that of outpatients (¥817.66). Among outpatients, direct and indirect medical costs contributed almost equally to the total expenditure, whereas inpatient costs were dominated by direct medical expenses. The median intangible cost was ¥5,000 for outpatients and ¥8,000 for inpatients. GLM analysis showed that prolonged disease duration, higher household income, and payment method were significantly associated with increased economic burden ( p < 0.05). Among inpatients, chronic comorbidities were also a significant determinant ( p < 0.05). Total costs increased progressively with longer disease duration. Conclusion: Mycoplasma pneumoniae infection imposes a considerable economic burden on patients in China, particularly among children, with cost structures differing between outpatient and inpatient settings. Early diagnosis, improved outpatient reimbursement policies, and future MP vaccine development may help reduce the economic burden.
- 1 June 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1835645
Open AccessEconomic burden of Mycoplasma pneumoniae infection in Jinhua City, China: a multicenter cross-sectional study
Background: Mycoplasma pneumoniae (MP) infection is a major cause of respiratory tract infections, particularly among children. However, quantitative evidence regarding its economic burden in China remains limited. Methods: A multicenter cross-sectional study was performed in Jinhua, China. Between October 2024 and March 2025, patients with laboratory-confirmed MP infection were enrolled using a multistage stratified random sampling approach. Data regarding direct, indirect, and intangible costs were collected via structured questionnaires and hospital information systems. Univariate analyses and generalized linear models (GLM) with a gamma distribution and log link function were employed to explore factors associated with the economic burden of MP infection. Results: A total of 582 patients were included, comprising 372 outpatients and 210 inpatients. The mean total cost per inpatient (¥6,289.21) was 7.69 times higher than that of outpatients (¥817.66). Among outpatients, direct and indirect medical costs contributed almost equally to the total expenditure, whereas inpatient costs were dominated by direct medical expenses. The median intangible cost was ¥5,000 for outpatients and ¥8,000 for inpatients. GLM analysis showed that prolonged disease duration, higher household income, and payment method were significantly associated with increased economic burden ( p < 0.05). Among inpatients, chronic comorbidities were also a significant determinant ( p < 0.05). Total costs increased progressively with longer disease duration. Conclusion: Mycoplasma pneumoniae infection imposes a considerable economic burden on patients in China, particularly among children, with cost structures differing between outpatient and inpatient settings. Early diagnosis, improved outpatient reimbursement policies, and future MP vaccine development may help reduce the economic burden.
- 26 May 2026
- Published by Taylor & Francis in International Journal of Environmental Health Research
- Vol. 36 (11) , 3082-3092
Short-term exposure to air pollution and Mycoplasma pneumoniae infection risk: a distributed lag nonlinear analysis
Mycoplasma pneumoniae (MP) is a major cause of community-acquired respiratory infections, particularly among children, (Meyer Sauteur et al. 2024, and is responsible for recurrent outbreaks with su...
- 26 May 2026
- Published by Taylor & Francis in International Journal of Environmental Health Research
- Vol. 36 (11) , 3082-3092
Short-term exposure to air pollution and Mycoplasma pneumoniae infection risk: a distributed lag nonlinear analysis
Mycoplasma pneumoniae (MP) is a major cause of community-acquired respiratory infections, particularly among children, (Meyer Sauteur et al. 2024, and is responsible for recurrent outbreaks with su...
- Open Access
Characteristics of Varicella Breakthrough Cases in Jinhua City, 2016–2024
Background: Varicella remains a prevalent vaccine-preventable disease, but breakthrough infections are increasingly reported. However, long-term, population-based studies investigating the temporal and demographic characteristics of breakthrough varicella remain limited. Methods: This retrospective study analyzed surveillance data from Jinhua City, China, from 2016 to 2024. Varicella case records were obtained from the China Information System for Disease Control and Prevention (CISDCP), while vaccination data were retrieved from the Zhejiang Provincial Immunization Program Information System (ISIS). Breakthrough cases were defined as infections occurring more than 42 days after administration of the varicella vaccine. Differences in breakthrough interval were analyzed across subgroups defined by dose, sex, age, population category, and vaccination type. A bivariate cubic regression model was used to assess the combined effect of initial vaccination age and dose interval on the breakthrough interval. Results: Among 28,778 reported varicella cases, 7373 (25.62%) were classified as breakthrough infections, with a significant upward trend over the 9-year period (p < 0.001). Most cases occurred in school-aged children, especially those aged 6–15 years. One-dose recipients consistently showed shorter breakthrough intervals than two-dose recipients (M = 62.10 vs. 120.10 months, p < 0.001). Breakthrough intervals also differed significantly by sex, age group, population category, and vaccination type (p < 0.05). Regression analysis revealed a negative correlation between the initial vaccination age, the dose interval, and the breakthrough interval (R2 = 0.964, p < 0.001), with earlier and closely spaced vaccinations associated with longer protection. Conclusions: The present study demonstrates that a two-dose varicella vaccination schedule, when initiated at an earlier age and administered with a shorter interval between doses, provides more robust and longer-lasting protection. These results offer strong support for incorporating varicella vaccination into China’s National Immunization Program to enhance vaccine coverage and reduce the public health burden associated with breakthrough infections.
Open AccessCharacteristics of Varicella Breakthrough Cases in Jinhua City, 2016–2024
Background: Varicella remains a prevalent vaccine-preventable disease, but breakthrough infections are increasingly reported. However, long-term, population-based studies investigating the temporal and demographic characteristics of breakthrough varicella remain limited. Methods: This retrospective study analyzed surveillance data from Jinhua City, China, from 2016 to 2024. Varicella case records were obtained from the China Information System for Disease Control and Prevention (CISDCP), while vaccination data were retrieved from the Zhejiang Provincial Immunization Program Information System (ISIS). Breakthrough cases were defined as infections occurring more than 42 days after administration of the varicella vaccine. Differences in breakthrough interval were analyzed across subgroups defined by dose, sex, age, population category, and vaccination type. A bivariate cubic regression model was used to assess the combined effect of initial vaccination age and dose interval on the breakthrough interval. Results: Among 28,778 reported varicella cases, 7373 (25.62%) were classified as breakthrough infections, with a significant upward trend over the 9-year period (p < 0.001). Most cases occurred in school-aged children, especially those aged 6–15 years. One-dose recipients consistently showed shorter breakthrough intervals than two-dose recipients (M = 62.10 vs. 120.10 months, p < 0.001). Breakthrough intervals also differed significantly by sex, age group, population category, and vaccination type (p < 0.05). Regression analysis revealed a negative correlation between the initial vaccination age, the dose interval, and the breakthrough interval (R2 = 0.964, p < 0.001), with earlier and closely spaced vaccinations associated with longer protection. Conclusions: The present study demonstrates that a two-dose varicella vaccination schedule, when initiated at an earlier age and administered with a shorter interval between doses, provides more robust and longer-lasting protection. These results offer strong support for incorporating varicella vaccination into China’s National Immunization Program to enhance vaccine coverage and reduce the public health burden associated with breakthrough infections.